Monday, 15 June 2015

PharmaPoint: Irritable Bowel Syndrome Drugs Market Analysis Report to 2023


Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a considerable effect on patients' quality of life (QOL). In terms of volume, the IBS market is a large, albeit naive, one, with only a small number of pharmacotherapies indicated for the treatment of the disorder, and it is also characterized by significant unmet needs.  

The key growth drivers for the IBS market in Japan are the anticipated label expansion of Astellas' Irribow for the treatment of women with IBS-D, and the potential introduction of five additional therapies for IBS during the forecast period. Antidepressants represented the remaining 32% of the market. The anticipated label expansion of Irribow for treating women with IBS-D, and the potential introduction of five new therapies for IBS, is set to change the IBS market dynamics in Japan.  


- Overview of Irritable Bowel Syndrome including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. 
- Detailed information on the key drugs in the Japan including product description, safety and efficacy profiles as well as a SWOT analysis. 
- Sales forecast for the top drugs in the Japan from 2013-2023. 
- Analysis of the impact of key events as well the drivers and restraints affecting the Japan Irritable Bowel Syndrome.  

Read Complete Report with TOC: 

Reasons To Buy  

- Understand and capitalize by identifying products that are most likely to ensure a robust return 
- Stay ahead of the competition by understanding the changing competitive landscape for Irritable Bowel Syndrome 
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential 
- Make more informed business decisions from insightful and in-depth analysis of drug performance - Obtain sales forecast for drugs from 2013-2023 in the Japan

About Us

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. 

For More Information Visit - Radiant Insights

Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Toll Free: 1-888-202-9519

No comments:

Post a Comment